In adult [2–4] and pediatric [5] CKD, levels of FGF23 are greatly increased, which contribute to CKD-MBD pathogenesis and have been associated with multisystemic co-morbidity and mortality [6–14]. This evidence concerns the gene FGF23 and chronic kidney disease.